EWA
ORKA

EverSource Wealth Advisors’s Oruka Therapeutics ORKA Stock Holding History

EverSource Wealth Advisors’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.6K Buy
847
+829
+4,606% +$55.2K ﹤0.01% 1494
2026
Q1 		$883 Buy
18
+2
+13% +$70 ﹤0.01% 3896
2025
Q4 		$485 Hold
16
– – ﹤0.01% 3883
2025
Q3 		$308 Buy
+16
New +$237 ﹤0.01% 4048

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

EverSource Wealth Advisors's ORKA Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Oruka Therapeutics (ORKA) stake by 4,606% in Q2 2026, buying an estimated $55.2K and bringing the position to 847 shares worth $80.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1494.

EverSource Wealth Advisors first reported a position in ORKA in Q3 2025 and has held it in 4 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • EverSource Wealth Advisors held 847 shares of Oruka Therapeutics worth $80.6K as of Q2 2026.
  • EverSource Wealth Advisors bought 829 Oruka Therapeutics shares in Q2 2026, an estimated $55.2K.
  • Oruka Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1494 holding.
  • EverSource Wealth Advisors first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.